The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro

Sun,Xiaodong; Han,Fang; Yi,Junling; Hou,Ningning; Cao,Zhibin

doi:10.3892/mmr.2013.1350

The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro

Authors:
- Xiaodong Sun
- Fang Han
- Junling Yi
- Ningning Hou
- Zhibin Cao
View Affiliations

Affiliations: Department of Endocrinology, The Affiliated Hospital of Weifang Medical University, Weifang, Shangdong 261031, P.R. China, Department of Pathology, The Affiliated Hospital of Weifang Medical University, Weifang, Shangdong 261031, P.R. China, Department of Obstetrics, Qingdao Municipal Hospital (East), Qingdao, Shandong 266003, P.R. China
Published online on: February 28, 2013 https://doi.org/10.3892/mmr.2013.1350
Pages: 1636-1640

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Serious complications as a result of type 2 diabetes mellitus (T2DM) are becoming a major health concern. In the present study, it was hypothesized that telomerase activity is upregulated in vascular smooth muscle cells (VSMCs) during proliferation in T2DM and that the application of telomerase inhibitors impedes the proliferation of VSMCs in vitro. Male Wistar rats were randomly allocated into the normal control (NC) or diabetic (DM) group. Diabetes was induced by high‑fat feeding and a low dose of streptozotocin (STZ; 30 mg/kg). Primary VSMC cultures were exposed to normal (5.5 mM) or high (25 mM) glucose and insulin (100 nM) in the presence and absence of various concentrations of antisense oligoribonucleotides (ASODNs) for varying lengths of time. Telomerase activity and the proliferation of VSMCs were measured. Results showed that there was a significant increase in the levels of fasting glucose, insulin, triglycerides (TG) and free fatty acids (FFAs) in the diabetic group. Telomerase activity and the proliferation of VSMCs were significantly higher in the diabetic group in vivo and in the high glucose and insulin (HGI)-treated group in vitro (P<0.01). ASODNs significantly inhibited the proliferation of VSMCs in a concentration- and time‑dependent manner (P<0.01). In conclusion, hyperglycemia and hyperinsulinemia stimulate telomerase activity and the proliferation of VSMCs, while the inhibition of telomerase activity reduces the proliferation of VSMCs, indicating that telomerase may be involved in the pathological process of diabetic vascular disease.

View Figures

View References

1	Bruemmer D and Law RE: Thiazolidinedione regulation of smooth muscle cell proliferation. Am J Med. 115:87–92. 2003. View Article : Google Scholar
2	Carmody BJ, Arora S, Wakefield MC, Weber M, Fox CJ and Sidawy AN: Progesterone inhibits human infragenicular arterial smooth muscle cell proliferation induced by high glucose and insulin concentrations. J Vasc Surg. 36:833–838. 2002. View Article : Google Scholar
3	Cifarelli V, Luppi P, Tse HM, He J, Piganelli J and Trucco M: Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-κB activation in vascular smooth muscle cells. Atherosclerosis. 201:248–257. 2008.PubMed/NCBI
4	Isenović ER, Kedees MH, Tepavcević S, Milosavljević T, Korićanac G, Trpković A and Marche P: Role of PI3K/AKT, cPLA2 and ERK1/2 signaling pathways in insulin regulation of vascular smooth muscle cells proliferation. Cardiovasc Hematol Disord Drug Targets. 9:172–180. 2009.PubMed/NCBI
5	Gizard F, Nomiyama T, Zhao Y, et al: The PPARalpha/p16INK4a pathway inhibits vascular smooth muscle cell proliferation by repressing cell cycle-dependent telomerase activation. Circ Res. 103:1155–1163. 2008. View Article : Google Scholar
6	Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L and Williams B: Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res. 102:201–208. 2008. View Article : Google Scholar
7	Jacob T, Hingorani A and Ascher E: Evidence for telomerase activation in VSMCs exposed to hyperglycemic and hyperhomocysteinemic conditions. Angiology. 60:562–568. 2009. View Article : Google Scholar : PubMed/NCBI
8	Serrano AL and Andrés V: Telomeres and cardiovascular disease: does size matter? Circ Res. 94:575–584. 2004. View Article : Google Scholar : PubMed/NCBI
9	Gancarcíková M, Zemanová Z, Brezinová J, Berková A, Vcelíková S, Smigová J and Michalová K: The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease. Prague Med Rep. 111:91–105. 2010.PubMed/NCBI
10	Jones CH, Pepper C and Baird DM: Telomere dysfunction and its role in haematological cancer. Br J Haematol. 156:573–587. 2012. View Article : Google Scholar : PubMed/NCBI
11	Sprouse AA, Steding CE and Herbert BS: Pharmaceutical regulation of telomerase and its clinical potential. J Cell Mol Med. 16:1–7. 2012. View Article : Google Scholar : PubMed/NCBI
12	Cesselli D, Beltrami AP, D’Aurizio F, et al: Effects of age and heart failure on human cardiac stem cell function. Am J Pathol. 179:349–366. 2011. View Article : Google Scholar : PubMed/NCBI
13	El Assar M, Angulo J, Vallejo S, Peiró C, Sánchez-Ferrer CF and Rodríguez-Mañas L: Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol. 3:1322012.PubMed/NCBI
14	Fyhrquist F and Saijonmaa O: Telomere length and cardiovascular aging. Ann Med. 44(Suppl 1): S138–S142. 2012. View Article : Google Scholar
15	Cao Y, Li H, Mu FT, Ebisui O, Funder JW and Liu JP: Telomerase activation causes vascular smooth muscle cell proliferation in genetic hypertension. FASEB J. 16:96–98. 2002.PubMed/NCBI
16	Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD and Yorek MA: ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes. 55:341–348. 2006. View Article : Google Scholar : PubMed/NCBI
17	Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ and Fu ZW: Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr. 16(Suppl 1): 412–417. 2007.PubMed/NCBI
18	Wang Y, Qiao L, Qiu J, Mi W, Han Y and Zhong C: Establishing primary cultures of vascular smooth muscle cells from the spiral modiolar artery. Int J Pediatr Otorhinolaryngol. 76:1082–1086. 2012. View Article : Google Scholar : PubMed/NCBI
19	He X, Qiao Q, Ge N, et al: Irradiation-induced telomerase activity and gastric cancer risk: a case-control analysis in a Chinese Han population. BMC Cancer. 10:3122010. View Article : Google Scholar : PubMed/NCBI
20	Huang J, Li LS, Yang DL, Gong QH, Deng J and Huang XN: Inhibitory effect of ginsenoside rg1 on vascular smooth muscle cell proliferation induced by PDGF-BB is involved in nitric oxide formation. Evid Based Complement Alternat Med. 2012:3143952012. View Article : Google Scholar
21	McMurray HF, Parrott DP and Bowyer DE: A standardised method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cells. Atherosclerosis. 86:227–237. 1991. View Article : Google Scholar
22	Sun X, Han F, Yi J, Han L and Wang B: Effect of aspirin on the expression of hepatocyte NF-kappaB and serum TNF-alpha in streptozotocin-induced type 2 diabetic rats. J Korean Med Sci. 26:765–770. 2011. View Article : Google Scholar : PubMed/NCBI
23	Jacob T, Clouden N, Hingorani A and Ascher E: The effect of cotinine on telomerase activity in human vascular smooth muscle cells. J Cardiovasc Surg (Torino). 50:345–349. 2009.PubMed/NCBI
24	Belair CD, Yeager TR, Lopez PM and Reznikoff CA: Telomerase activity: a biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA. 94:13677–13682. 1997. View Article : Google Scholar : PubMed/NCBI
25	Matthews C, Gorenne I, Scott S, et al: Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 99:156–164. 2006. View Article : Google Scholar
26	Chen H, Li Y and Tollefsbol TO: Strategies targeting telomerase inhibition. Mol Biotechnol. 41:194–199. 2009. View Article : Google Scholar : PubMed/NCBI